Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

6.02
-0.5200-7.95%
Post-market: 6.020.00000.00%19:20 EDT
Volume:534.13K
Turnover:3.21M
Market Cap:148.85M
PE:-1.69
High:6.51
Open:6.51
Low:5.78
Close:6.54
52wk High:8.82
52wk Low:3.53
Shares:24.73M
Float Shares:19.13M
Volume Ratio:1.77
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5649
EPS(LYR):-3.5649
ROE:-62.71%
ROA:-22.42%
PB:1.61
PE(LYR):-1.69

Loading ...

FDA grants Fast Track designation to Precision BioSciences’ PBGENE-DMD for Duchenne muscular dystrophy

Reuters
·
Mar 09

Precision BioSciences Receives FDA Fast Track Designation for Pbgene-Dmd and Announces Duchenne Muscular Dystrophy Investor Event

THOMSON REUTERS
·
Mar 09

Precision BioSciences Receives $7.5 Million Milestone Payment From TG Therapeutics for Azer-cel MS Trial Progress

Reuters
·
Mar 02

Precision BioSciences Inc - Cash Received Supports Precision's Runway Through 2028

THOMSON REUTERS
·
Mar 02

Precision BioSciences Receives $7.5M in Proceeds From TG Therapeutics for Azer-Cel Clinical Milestone in Multiple Sclerosis

THOMSON REUTERS
·
Mar 02

Precision BioSciences to Present PBGENE-DMD Preclinical Data at 2026 MDA Clinical & Scientific Conference

Reuters
·
Feb 18

BUZZ-U.S. STOCKS ON THE MOVE-Shopify, GlobalFoundries, Constellation Energy

Reuters
·
Feb 11

FDA Clears Precision BioSciences to Begin Clinical Trial for Duchenne Muscular Dystrophy Therapy

Reuters
·
Feb 11

Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class Pbgene-Dmd for Treatment of Duchenne Muscular Dystrophy

THOMSON REUTERS
·
Feb 11

JonesTrading Keeps Their Buy Rating on Precision BioSciences (DTIL)

TIPRANKS
·
Jan 23

Empery Asset Management Lp Reports 9.99% Passive Stake in Precision BioSciences as of Dec 31, 2025 - SEC Filing

THOMSON REUTERS
·
Jan 23

Precision BioSciences Announces 2026 Strategic Plan Focused on Advancing Clinical-Stage PBGENE-HBV and PBGENE-DMD Programs, Initiating DMD Clinical Trials, and Maintaining Cash Runway Through 2028

Reuters
·
Jan 12

BRIEF-Precision Biosciences Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
Dec 30, 2025

Precision BioSciences Inc: Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
Dec 30, 2025

Precision BioSciences Grants Inducement RSUs to New Employee

Reuters
·
Dec 23, 2025

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 23, 2025

Director Geno J. Germano Acquires Common Shares of Precision BioSciences Inc

Reuters
·
Dec 17, 2025

Director Melinda Brown Acquires Common Shares of Precision BioSciences Inc

Reuters
·
Dec 17, 2025

H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL)

TIPRANKS
·
Nov 21, 2025

Precision BioSciences Unveils Positive Phase 1 ELIMINATE-B Trial Results for PBGENE-HBV

Reuters
·
Nov 19, 2025